The Prostate Cancer Research Institute Presents
2023 ANNUAL PROSTATE CANCER PATIENT VIRTUAL CONFERENCE
AIRS ON SEPT 23-24, 2023: VIRTUAL | 8:30 AM PDT
FREE EVENT | RSVP TODAY!
The 2023 Prostate Cancer Patient Conference is a two-day online educational event for prostate cancer patients and caregivers. Join other patients and caregivers who will be attending from across the US and internationally. Renowned physicians from different specialties will be covering topics including advanced cancer, active surveillance, radiation treatment, imaging, erectile dysfunction, and incontinence. The conference is led by Mark Moyad, MD, who moderates the Q+A sessions following each lecture and ensures that our speaker’s answers are relevant to laypeople who are affected by prostate cancer. At the end of the conference, Drs. Mark Scholz and Mark Moyad host an extended Q+A session covering topics and questions that have been submitted by attendees.
CLICK THE VIDEO ABOVE TO WATCH DAY 1
CLICK THE VIDEO ABOVE TO WATCH DAY 2
THE AGENDA
AGENDA
Saturday, September 23, 2023 (all times in PAcific Daylight Time)
8:30am - 8:40am PDT | Opening Remarks with Mark Moyad, MD
8:40am - 10:40am PDT | Sexual Function After Prostate Cancer Treatment with John Mulhall, MD
10:40am - 12:20pm PDT | Brachytherapy 101 with Steve Kurtzman, MD & Ankit Agarwal, MD
12:20pm - 12:45pm PDT | Learn More About Akeega | Sponsored Presentation
12:45pm - 2:00pm PDT | Advanced Prostate Cancer Update with Mark Scholz, MD
2:00pm PDT | Closing Remarks | Alex Scholz
SUNDAY, September 24, 2023
8:30am - 10:00am PDT | An Update on Active Surveillance with Matthew Cooperberg, MD
10:00am - 1:00pm PDT | Advanced Prostate Cancer Treatments & Side Effects with Eugene Kwon, MD
1:00pm - 1:30pm PDT | Sponsored Presentation
1:30pm - 1:45pm PDT | PCRI Honors Howard Wolinsky with the Harry Pinchot Award
1:45pm - 4:00pm PDT | 2023 Update | 10th Annual Moyad and Scholz Free for All! Any Question on Any Aspect of Prostate Cancer! | Mark Moyad, MD & Mark Scholz, MD
4:00pm | Closing Remarks
*Agenda is subject to change
EXHIBIT HALL
Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare, Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs.
This information has been reviewed according to the US law and is consistent with US Prescribing Information and is intended for US audience only. Prescribing Information may vary depending on local approval in each country.
Click here to learn more about Xofigo (radium Ra 223 dichloride)
Click here to learn more about NUBEQA (darolutamide)
For additional information, contact:
Rebecca Cowens-Alvarado, MPH
Deputy Director Advocacy Relations
Email: Rebecca.cowens-Alvarado@bayer.com
Product:
Erleada:
Prescribing Information:
Financial Resources:
Paying for ERLEADA:
https://www.erleada.com/paying-for-erleada
Know Your State Interactive Tool:
https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/know-your-state.pdf
EDUCATIONAL RESOURCES
Living With Cancer Website:
https://www.thisislivingwithcancer.com/living-with-app
Pfizer Virtual Booth: pfizeroncologycongressresources.com
Living With Cancer iTunes App:
https://apps.apple.com/us/app/id1223073769
Know Your Prostate Plan – Patient Videos
PROVENGE
PRESCRIBING INFORMATION:
https://www.provengehcp.com/Portals/5/Provenge-PI.pdf
OTHER RESOURCES:
Provenge Support Information
https://www.provenge.com/Support
Your Provenge Experience:
PRESCRIBING INFORMATION:
JEVTANA® (cabazitaxel) injection, for intravenous use Prescribing Information (sanofi.us)
PERSONAL AND FINANCIAL SUPPORT:
PAN FOUNDATION
We help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability.
RESOURCES:
The PAN Foundation: https://www.panfoundation.org/
Our disease funds: https://www.panfoundation.org/find-disease-fund/
Find patient assistance in minutes! Sign up for FundFinder: https://fundfinder.panfoundation.org/
Become an advocate: https://www.panfoundation.org/become-an-advocate/
SPEAKERS & TOPICS
2023 SPEAKERS + TOPICS
Professor of Urology; Epidemiology & Biostatistics | Chief of Urology, San Francisco VAMC
Active Surveillance
John Mulhall, MD
Director of the Male Sexual & Reproductive Medicine Program at Memorial Sloan Kettering Cancer Center
Sexual Function After Prostate Cancer Treatment
Eugene Kwon, MD
Professor of Urology, Professor of Immunology
Mayo Clinic
An UPDATE ON Advanced treatments & Side Effects IMAGING
Mark Scholz, MD
Medical Director, Prostate Oncology Specialists &
Executive Director, PCRI
ADVANCED PROSTATE CANCER TREATMENT & SIDE EFFECTs
&
10TH Annual Moyad and Scholz Free for All! Any question on any aspect of prostate cancer!!
Mark Moyad, MD, MPH
Jenkins/Pokempner Director of Preventive and Alternative Medicine Education, University of Michigan, Department of Urology
MODERATOR & 10TH Annual Moyad and Scholz Free for All! Any question on any aspect of prostate cancer!!
LEARN MORE ABOUT PCRI’S IMPACT
LEARN ABOUT ALL THAT PCRI HAS TO OFFER
The PCRI provides resources for prostate cancer patients and caregivers looking to gain understanding, insight, and hope. Get honest answers from science based data.
Hello Researcher! We are the Prostate Cancer Research Institute (PCRI), a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for you. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website with any question that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
